LEDIPASVIR (LDV)/SOFOSBUVIR (SOF) TREATMENT OF HEPATITIS C VIRUS (HCV) IS ASSOCIATED WITH REDUCTION OF SERUM APOLIPOPROTEIN LEVELS

被引：0
|
作者：
Younossi, Z. [1 ,2 ]
Elsheikh, E. [1 ,2 ]
Stepanova, M. [2 ]
Gerber, L. [2 ]
Nader, F. [1 ,2 ]
Brainard, D. [3 ]
McHutchinson, J. G. [3 ]
机构：
[1] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[3] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30934-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0731
引用
收藏
页码：S599 / S599
页数：1
相关论文
共 50 条
  • [1] Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels
    Younossi, Z. M.
    Elsheikh, E.
    Stepanova, M.
    Gerber, L.
    Nader, F.
    Stamm, L. M.
    Brainard, D. M.
    McHutchinson, J. G.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 (12) : 977 - 982
  • [2] Declines in HBsAg Levels Observed during Treatment with Ledipasvir/Sofosbuvir (LDV/SOF) in Patients with Chronic Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Infection
    Liu, Chun-Jen
    Chuang, Wan-Long
    Sheen, I-Shyan
    Wang, Horng-Yuan
    Chen, Chi-Yi
    Tseng, Kuo-Chih
    Chang, Ting-Tsung
    Massetto, Benedetta
    Osinusi, Anu O.
    Camus, Gregory
    Jiang, Deyuan
    Zhang, Fangqiu
    Brainard, Diana M.
    McHutchison, John G.
    Hu, Tsung-Hui
    Hsu, Yao-Chun
    Lo, Gin-Ho
    Chu, Chi-Jen
    Chen, Jyh-Jou
    Peng, Cheng-Yuan
    Chien, Rong-Nan
    Chen, Pei-Jer
    [J]. HEPATOLOGY, 2017, 66 : 579A - 580A
  • [3] THE LEVELS OF MONOAMINE NEUROTRANSMITTERS IN HCV PATIENTS TREATED WITH LEDIPASVIR (LDV)/SOFOSBUVIR (SOF)
    Golabi, P.
    Elsheikh, E.
    Karrar, A.
    Estep, J. M.
    Younossi, I.
    Stepanova, M.
    Gerber, L.
    Younossi, Z. M.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S630 - S630
  • [4] Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
    Ashley N. Brown
    Lin Liu
    Jaime L. Rodriquez
    Lisa Zhao
    Layla Schuster
    Eric Li
    Gary P. Wang
    Michael N. Neely
    Walter Yamada
    George L. Drusano
    [J]. Scientific Reports, 7
  • [5] Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
    Brown, Ashley N.
    Liu, Lin
    Rodriquez, Jaime L.
    Zhao, Lisa
    Schuster, Layla
    Li, Eric
    Wang, Gary P.
    Neely, Michael N.
    Yamada, Walter
    Drusano, George L.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [6] LONG-TERM OUTCOMES OF LEDIPASVIR/SOFOSBUVIR (LDV/ SOF) FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED (HCV) GENOTYPE 1 PATIENTS IN THE UK
    Guerra, I
    Marie, L.
    Cure, S.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A675 - A675
  • [7] Sustained virologic response (SVR) in patients taking ledipasvir-sofosbuvir (LDV/SOF) and a proton pump inhibitor (PPI) in the treatment of chronic hepatitis C virus (HCV)
    Mangum, Jordan E.
    Pillai, Anjana A.
    Wedd, Joel P.
    Todd, Sarah B.
    [J]. HEPATOLOGY, 2016, 64 : 1004A - 1004A
  • [8] Real-World Retreatment of Sofosbuvir/Ledipasvir (SOF/LDV) Failures In Hepatitis C Virus Genotype 1 infection
    Pearlman, Brian
    Hinds, Andrew
    Perrys, Michael
    [J]. HEPATOLOGY, 2016, 64 : 478A - 478A
  • [9] REACTIVATION OF HEPATITIS B VIRUS AMONG PATIENTS TREATED WITH LEDIPASVIR-SOFOSBUVIR (LDV/SOF) FOR HEPATITIS C VIRUS INFECTION IN A COMMUNITY BASED SETTING
    Yanny, Beshoy
    Sahota, Amandeep
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1059 - S1059
  • [10] SIX WEEKS OF SOFOSBUVIR/ LEDIPASVIR (SOF/LDV) ARE SUFFICIENT TO TREAT ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: THE HEPNET ACUTE HCV IV STUDY
    Deterding, K.
    Spinner, C.
    Schott, E.
    Welzel, T.
    Gerken, G.
    Klinker, H.
    Spengler, U.
    Wiegand, J.
    zur Wiesch, J. Schulze
    Pathil, A.
    Cornberg, M.
    Umgelter, A.
    Zoellner, C.
    Zeuzem, S.
    von der Leyen, H.
    von Witzendorff, D.
    Manns, M. P.
    Wedemeyer, H.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S211 - S211
12345